
Publication
Patenting biomarker-related AI / machine-learning innovations
Defining patent-eligible subject matter under 35 U.S.C. § 101 is an ongoing struggle for the United States Patent and Trademark Office.
We look at developments relating to employer covenant strength and scheme funding. This includes issues such as contingent assets, corporate restructurings, financial distress and insolvency.
Publication
Defining patent-eligible subject matter under 35 U.S.C. § 101 is an ongoing struggle for the United States Patent and Trademark Office.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2025